Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

IlluminOss Medical

Explore full profile

IlluminOss Medical, a medical device company, develops minimally invasive orthopedic systems for the treatment of bone fractures

East Providence, United StatesFounded 2007Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2016
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for IlluminOss Medical and the history behind them.

About IlluminOss Medical

IlluminOss Medical specializes in producing minimally invasive, patient-conforming orthopedic implants using its proprietary bone stabilization technology, known as the IlluminOss System. This system is designed to provide a new solution for osteoporotic and pathologic fracture repair by enabling a minimally invasive surgical approach that requires only a small incision for access and implant insertion, thereby minimizing potential soft tissue damage. The implants conform to the unique geometry of the intramedullary canal and can be used in conjunction with conventional plates, screws, and nails to enhance stability in compromised bone. The company's primary clients are physicians and healthcare providers who treat patients with osteoporotic fractures or other bone-related pathologies. Operating in the medical device market, IlluminOss generates revenue through the sale of its proprietary implants and related surgical tools. The business model focuses on providing innovative, effective, and less invasive solutions for bone stabilization, which can lead to quicker recovery times and improved patient outcomes.

Source: Dealroom company data

At a glance

Founded
2007
Headquarters
East Providence, United States
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning IlluminOss Medical.

See all news

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Foundation Medical Partners
  • Mieza Capital
  • New Leaf Venture Partners

Series B and later2 investors entered at this stage

  • EQT Life Sciences
  • Tekla Capital Management
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States85%
🇩🇪 Germany10%
🇳🇱 Netherlands5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about IlluminOss Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See IlluminOss Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.